Effective treatment of different H1-antihistaminerefractory chronic urticaria phenotypes with omalizumab
(Turk Arch Pediatr 2018; 53: 250-254) DOI: 10.5152/TurkPediatriArs.2016.4042
(Turk Arch Pediatr 2018; 53: 250-254) DOI: 10.5152/TurkPediatriArs.2016.4042